Patient Presentation A male in his early 70s with a history of diabetes mellitus, hypertension, hyperlipidemia, and COVID-19 ...

Biotronik announced the enrollment of the first patients in its BIO-OSCAR FIRST trial, which is designed to confirm the ...

Contego Medical announced the first commercial procedures were performed with the company’s Neuroguard IEP system. Ac ...

The true incidence of RTAD has not yet been established, but it is an increasingly observed phenomenon, with an estimated overall incidence of 1% to 4%. 3-6 In their recent systematic meta-analysis, ...

Patient Presentation A man in his late 50s presented to the emergency department with 4 weeks of acute-onset, severely ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...

Flow Medical announced the closing of a $5 million seed funding round that will allow the company to accelerate the ...

The Screening Abdominal Aortic Aneurysm Very Efficiently (SAAAVE) Act became law with President Bush's signing of S.1932, the Deficit Reduction Act of 2005, on February 8. Also known as the Budget ...

Fluid Biomed Inc. announced it closed a $27 million Series A equity financing round. The funds will be used to advance ...

Biotronik announced it has concluded the BIO-OSCAR SOC prospective, multicenter, observational trial, which established the ...

Materials, characteristics, and approaches for use. Currently used embolic agents for PAE include polyvinyl alcohol (PVA) particles (Bearing nsPVA, Merit Medical Systems, Inc.; Contour, Boston ...

Endovascular Today (ISSN 1551-1944 print and ISSN 2689-792X online) is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the ...